| 0 | 💬 0 |
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged >/=60 Years.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-05-20 | #vaccination #clinical trial #immunogenicity #safety #rsv | |
| 0 | 💬 0 |
Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-05-20 | #covid-19 #vaccination #immunity #immunogenicity #safety |